UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Gabelli Funds LLC

Gabelli Funds LLC lowered its position in UnitedHealth Group Incorporated (NYSE:UNH) by 1.8% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 39,975 shares of the healthcare conglomerate’s stock after selling 735 shares during the quarter. Gabelli Funds LLC’s holdings in UnitedHealth Group were worth $20,358,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Macroview Investment Management LLC lifted its position in UnitedHealth Group by 671.4% during the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after buying an additional 47 shares in the last quarter. Delos Wealth Advisors LLC lifted its holdings in shares of UnitedHealth Group by 757.1% during the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after acquiring an additional 53 shares in the last quarter. True Wealth Design LLC acquired a new stake in UnitedHealth Group in the 4th quarter valued at $31,000. Bbjs Financial Advisors LLC acquired a new position in shares of UnitedHealth Group during the second quarter worth about $31,000. Finally, Signature Resources Capital Management LLC grew its stake in shares of UnitedHealth Group by 40.0% in the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock valued at $32,000 after buying an additional 18 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the transaction, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The disclosure for this sale can be found here. 0.33% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on UNH shares. TD Cowen upped their price target on UnitedHealth Group from $546.00 to $601.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. UBS Group raised their price target on shares of UnitedHealth Group from $640.00 to $680.00 and gave the company a “buy” rating in a report on Thursday, July 18th. Baird R W upgraded shares of UnitedHealth Group to a “strong-buy” rating in a report on Thursday, May 30th. JPMorgan Chase & Co. lifted their target price on UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a research report on Thursday, May 30th. Finally, Argus raised their price objective on UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. One analyst has rated the stock with a hold rating, nineteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $614.17.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $575.00 on Monday. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67. The firm’s 50-day moving average price is $577.10 and its two-hundred day moving average price is $521.14. The stock has a market capitalization of $529.22 billion, a P/E ratio of 35.15, a P/E/G ratio of 1.64 and a beta of 0.58. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $607.94.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, topping the consensus estimate of $6.66 by $0.14. The firm had revenue of $98.86 billion for the quarter, compared to analyst estimates of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The firm’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same period last year, the company earned $6.14 earnings per share. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be given a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.46%. UnitedHealth Group’s dividend payout ratio is presently 51.34%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.